Published in Circulation on January 01, 1984
Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? Int J Cardiovasc Imaging (2008) 2.96
Brugada syndrome. Pacing Clin Electrophysiol (2006) 2.61
Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function. J Cardiovasc Magn Reson (2013) 1.18
Brugada syndrome: from cell to bedside. Curr Probl Cardiol (2005) 1.08
Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs. Neuromuscul Disord (2011) 1.04
Feline muscular dystrophy with dystrophin deficiency. Am J Pathol (1989) 1.03
Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson (2008) 1.01
Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart. J Mol Cell Cardiol (2009) 0.99
Abnormal circumferential strain is present in young Duchenne muscular dystrophy patients. Pediatr Cardiol (2013) 0.96
Echocardiographic evaluation of fibrous replacement in the myocardium of patients with Duchenne muscular dystrophy. Br Heart J (1991) 0.95
Cardiopulmonary support in duchenne muscular dystrophy. Lung (2006) 0.93
Cardiac spectroscopy: techniques, indications and clinical results. Eur Radiol (2004) 0.87
Ankyrin-based cellular pathways for cardiac ion channel and transporter targeting and regulation. Semin Cell Dev Biol (2010) 0.87
Cardiac involvement in Duchenne and Becker muscular dystrophy. World J Cardiol (2015) 0.87
Early detection of cardiac involvement in Miyoshi myopathy: 2D strain echocardiography and late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2010) 0.82
Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging. Pediatr Cardiol (2015) 0.78
Role of myocardial perfusion single photon emission computed tomography in pediatric cardiology practice. Ann Pediatr Cardiol (2009) 0.78
Mapping contrast agent uptake and retention in MRI studies of myocardial perfusion: case control study of dogs with Duchenne muscular dystrophy. Int J Cardiovasc Imaging (2012) 0.76
Positron emission tomography in paediatric cardiology. Arch Dis Child (1998) 0.76
Early myocardial damage assessment in dystrophinopathies using (99)Tc(m)-MIBI gated myocardial perfusion imaging. Ther Clin Risk Manag (2015) 0.75
Cardiac positron emission tomography. West J Med (1985) 0.75
Radiology: positron-emission tomography of the heart. West J Med (1985) 0.75
The Use of Speckle Tracking Echocardiography for Early Detection of Myocardial Dysfunction in Patients with Duchenne Muscular Dystrophy. Pediatr Cardiol (2016) 0.75
Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation (1990) 7.87
Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation (1996) 2.31
Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation (2001) 2.29
The cardiomyopathy of progressive muscular dystrophy. Circulation (1966) 2.21
The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA (1989) 2.17
Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol (2000) 2.14
Mitral valve prolapse. Circulation (1976) 2.05
The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation (1972) 1.93
Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation (1993) 1.81
Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation (1999) 1.80
13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation (1989) 1.77
Mitral valvular disease. A clinicopathologic survey of the conditions causing the mitral valve to function abnormally. Ann Intern Med (1972) 1.76
Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol (1990) 1.73
Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine. Nucl Med Commun (1996) 1.67
Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation (1995) 1.54
A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. J Nucl Med (1993) 1.53
Evolving concepts of mitral-valve prolapse. N Engl J Med (1982) 1.52
The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. An electrocardiographic-pathologic correlative study. Am J Med (1967) 1.52
Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1989) 1.51
A quantitative index of regional blood flow in canine myocardium derived noninvasively with N-13 ammonia and dynamic positron emission tomography. J Am Coll Cardiol (1991) 1.46
Radiotherapy with iodine-131 in recurrent malignant struma ovarii. Eur J Nucl Med (1996) 1.43
Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction. J Nucl Cardiol (1999) 1.42
Ostium secundum atrial septal defect--survival for 87 and 94 years. Am J Cardiol (1984) 1.42
Evidence for preserved cardiopulmonary baroreflex control of renal cortical blood flow in humans with advanced heart failure. A positron emission tomography study. Circulation (1995) 1.41
Age- and sex-related bone uptake of Tc-99m-HDP measured by whole-body bone scanning. Nuklearmedizin (2000) 1.39
The exercise test as a diagnostic and therapeutic aid. Am Heart J (1974) 1.38
Noninvasive quantification of hepatic arterial blood flow with nitrogen-13-ammonia and dynamic positron emission tomography. J Nucl Med (1991) 1.38
Cardiac involvement in Friedreich's ataxia: a clinical study of 75 patients. J Am Coll Cardiol (1986) 1.36
Factor analysis for extraction of blood time-activity curves in dynamic FDG-PET studies. J Nucl Med (1995) 1.36
N-13 ammonia as an indicator of myocardial blood flow. Circulation (1981) 1.35
Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation (1995) 1.32
Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation (1983) 1.32
Serial measurements of left ventricular ejection fraction by radionuclide angiography early and late after myocardial infarction. Am J Cardiol (1976) 1.32
Electrophysiologic characteristics of Ebstein's anomaly of the tricuspid valve. Circulation (1975) 1.31
Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med (1989) 1.30
Medical perspectives in coronary artery surgery--a caveat. Ann Intern Med (1974) 1.25
Systemic venous and pulmonary arterial flow patterns after Fontan's procedure for tricuspid atresia or single ventricle. Circulation (1984) 1.24
Severe valvular aortic stenosis in patients over 65 years of age. A clinicopathologic study. Am J Cardiol (1971) 1.23
Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis (2004) 1.22
Acute severe aortic regurgitation. Pathophysiology, clinical recognition, and management. Ann Intern Med (1977) 1.19
Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. Circulation (1996) 1.19
New guidelines for the clinical diagnosis of mitral valve prolapse. Am J Cardiol (1986) 1.17
Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll Cardiol (1999) 1.15
Cardiomyopathy associated with heredofamilial neuromyopathic diseases. Mod Concepts Cardiovasc Dis (1971) 1.14
Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): a prospective study of 25 patients. Am J Cardiol (1984) 1.13
Congenital aortic stenosis resulting from a unicommisssural valve. Clinical and anatomic features in twenty-one adult patients. Circulation (1971) 1.13
Anesthetic implications of adults with congenital heart disease. Anesth Analg (1993) 1.13
Serious complications after radiosynoviorthesis. Survey on frequency and treatment modalities. Nuklearmedizin (2006) 1.12
S100B protein detection in serum is a significant prognostic factor in metastatic melanoma. Oncology (1999) 1.12
Quantification of regional myocardial blood flow using 13N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation (1992) 1.12
Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg (1998) 1.11
Aneurysm of the nonpatent ductus arteriosus. Am J Cardiol (1972) 1.11
Canadian Consensus Conference on Adult Congenital Heart Disease 1996. Can J Cardiol (1998) 1.11
Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med (1996) 1.10
Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease. Lancet (1986) 1.10
Nontraumatic determination of left ventricular ejection fraction by radionuclide angiocardiography. Circulation (1975) 1.10
Pediatric congenital cardiac becomes a postoperative adult. The changing population of congenital heart disease. Circulation (1973) 1.08
Derivation of input function from FDG-PET studies in small hearts. J Nucl Med (1996) 1.08
Acquired subvalvular right ventricular outflow obstruction in patients with ventricular septal defect. Am J Med (1972) 1.07
Radionuclide angiographic evaluation of ventricular function in isolated congenitally corrected transposition of the great arteries. Am J Cardiol (1986) 1.07
Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. Circulation (1998) 1.07
Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol (1992) 1.07
Long-term results of radiation synovectomy: a clinical follow-up study. Nucl Med Commun (2001) 1.06
Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (1987) 1.06
Myocardial imaging with thallium-201: a multicenter study in patients with angina pectoris or acute myocardial infarction. Am J Cardiol (1978) 1.06
Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvement. J Am Coll Cardiol (1990) 1.05
Coronary arterial spasm versus esophageal spasm. Response to ergonovine. Am J Med (1981) 1.05
Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am J Cardiol (1979) 1.02
Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol (1987) 1.02
Surgical closure of atrial septal defect in adults. N Engl J Med (1995) 1.02
Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver. J Nucl Med (1994) 1.02
Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies. J Nucl Med (1991) 1.02
Validation of a model for [1-11C]acetate as a tracer of cardiac oxidative metabolism. Am J Physiol (1994) 1.01
Left ventricular ejection fraction--a review of several radionuclide angiographic approaches using the scintillation camera. Prog Cardiovasc Dis (1978) 1.01
Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11]acetate. J Nucl Med (1998) 1.00
Pregnancy and congenital heart disease. Ann Intern Med (1990) 1.00
Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients. Melanoma Res (1999) 1.00
Positron computed tomography for studies of myocardial and cerebral function. Ann Intern Med (1983) 1.00
Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med (1982) 1.00
Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography. Circulation (1989) 1.00
Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med (1993) 0.99
Cardiac rhythm and conduction in Duchenne's muscular dystrophy: a prospective study of 20 patients. J Am Coll Cardiol (1984) 0.99
The isolated systolic click with bacterial endocarditis. Am Heart J (1967) 0.99
Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography. Circulation (1989) 0.98
Ventricular septal defect with the "two-chambered right ventricle". Am J Cardiol (1965) 0.98
Nomograms for the prediction of patient's plasma volume in plasma exchange therapy from height, weight, and hematocrit. J Clin Apher (1987) 0.97
The UCLA Adult Congenital Heart Disease Program. Am J Cardiol (1986) 0.97
Inhibition of glyceraldehyde-3-phosphate dehydrogenase in post-ischaemic myocardium. Cardiovasc Res (1996) 0.97
Isolated dextroversion of the heart with asymmetric septal hypertrophy. Am Heart J (1976) 0.96
Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol (1985) 0.96
Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. J Nucl Med (1995) 0.96
Cardiac conduction in the Kearns-Sayre syndrome (a neuromuscular disorder associated with progressive external ophthalmoplegia and pigmentary retinopathy). Report of 2 cases and review of 17 published cases. Am J Cardiol (1979) 0.96
Dual myocardial imaging with technetium-99m pyrophosphate and thallium-201 for detecting, localizing and sizing acute myocardial infarction. Am J Cardiol (1977) 0.96
Right ventricular ejection fraction in patients with acute anterior and inferior myocardial infarction assessed by radionuclide angiography. Circulation (1978) 0.96
Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy. Br J Dermatol (1999) 0.96
Radiolabeled acetate as a tracer of myocardial tricarboxylic acid cycle flux. Circ Res (1988) 0.96